The U.S. Food and Drug Administration has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver dise... Read more
Now that the U.S. Supreme Court has upheld The Patient Protection And Affordable Care Act as being constitutional, folks are beginning to learn much more about the good features of this badl... Read more
It’s apparent that the fraudulent billing of Medicare/Medicaid, primarily by pharmaceutical companies, are increasing our nation’s healthcare costs. Over the past few years, we have seen num... Read more
There is certainly room for serious debate over what has caused the extremely high costs of healthcare in this country. We hear the cry each year for limits on the rights of individuals to r... Read more
Vanguard Healthcare, a Tennessee health care firm, has agreed to pay back some $2 million to the federal government in the latest in a series of Medicare and Medicaid fraud cases brought by... Read more
The U.S. Supreme Court has agreed to decide the fate of President Barack Obama’s healthcare law, with an election-year ruling due by July on the U.S. healthcare system’s biggest overhaul in... Read more
A recent study involving children taking stimulant drugs such as Ritalin to treat attention-deficit hyperactivity disorder has caused a stir in the medical community. The study revealed that... Read more
The Food and Drug Administration says Zicam nasal spray can permanently damage users’ sense of smell. The FDA says consumers should stop using Zicam Cold Remedy nasal gel and related p... Read more
An international consortium of industry, academic and government scientists has rejected as incomplete and unreliable the U.S. Food and Drug Administration’s position that a chemical f... Read more
If anyone needed further evidence that there are serious problems with the Food and Drug Administration’s regulation and approval of medical devices, I believe all doubts have now been erase... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.